Procurement Bill [Lords]

Debate between Paul Howell and Jeremy Quin

2nd reading
Monday 9th January 2023 Commons Chamber

[Jeremy Quin]

I thank my hon. Friend for the ideas he threw in our direction, which have been picked up. He is right to say that greater transparency is absolutely reflected in this Bill, and I thank him for the work he did. There has been a long lead-up to get to this Bill and we thank him very much for his support. I am proud of the evaluation task force and the work it does, not only on procurement, but on other areas of policy, looking into them to make certain that they are delivering what we intended when they were announced. That is an important tool for all Governments. I would love to see the evaluation task force grow. It is growing in experience and in the amount of projects it is taking on. It has covered a fair bit of the waterfront, but I appreciate that it is merely a small element at the moment and I would like to see it grow. However, he will forgive me if I do not start making commitments of that sort at the Dispatch Box—

[Paul Howell (Sedgefield) (Con)]

When we talk about NHS procurement and the challenges for small and medium-sized enterprises in dealing with the NHS, we are talking about small companies dealing with a vast organisation. PolyPhotonix, a company in my constituency, gave me an example of the frustration involved. It created a light therapy mask to help treat diabetic retinopathy, and I have been supporting the company. The NHS procurement process has been extremely complex, although the company got the mask approved. There was NHS investment in innovation to develop it, but it became used in the private sector before the NHS, because the NHS procurement could not get it right or could not make the approvals. Those were finally obtained and the mask is now active, fabulous and a great product. The other NHS trusts all want to approve it themselves, so surely there is an opportunity here. If something is approved by one NHS trust, surely it does not need to be approved by every other one before it can be used. Is there some opportunity in the Bill to facilitate that greater ease for SMEs?

[Jeremy Quin]

I recognise the frustration of the company in my hon. Friend’s constituency. He should take up the specifics of that with my right hon. Friend the Health Secretary, but more generally he raises an extremely valuable point, not just in the health sector, but more broadly, about the ease of doing business with Government for SMEs. The Bill contains a range of measures on this: it puts a duty on procurers to ensure that they are considering the specific needs of SMEs; it ensures there is a 30-day payment period; it ensures that pipelines are put out well in advance; it says, “You don’t need to be insured to do the job before you have won it”; and, above all, it provides for one entry point and allows companies to set out in one place what they are as a smaller company before they even start thinking about the tender they are applying for. All those are incredibly valuable components to make it easier for an SME to thrive.

Oral Answers to Questions

Debate between Paul Howell and Jeremy Quin

Monday 18th July 2022 Commons Chamber

[Jeremy Quin]

My hon. Friend is right about that threat, and he is right to suggest that we need to be absolutely on our toes in dealing with it. The Department continuously integrates leading-edge innovative cyber-technologies into military operations, including intelligence agents for autonomous resilience cyber-defence and cyber-deception technologies, through the National Cyber Deception Laboratory. In doing so, we make active use of DASA funding and the excellent expertise that we have in the Defence Science and Technology Laboratory.

[Paul Howell]

As we see in the tragedy that is happening to Ukraine, the normal boundaries of warfare are being ignored, with increasing risks of the employment of biological or viral warfare strategies. Does my hon. Friend agree that we need to be at the forefront of innovation and research to deliver the best possible platforms to defend against these abhorrent strategies, and that the work that companies such as Kromek in Sedgefield are doing in collaboration with others deserves full support and indeed acceleration?

[Jeremy Quin]

I am familiar with Kromek and its capabilities, and my hon. Friend is absolutely right to say that it is often SMEs that produce the most brilliant ideas, often working with excellent British universities. DASA finds and supports new ideas within defence, and I am delighted that SMEs make up some two thirds of the projects that DASA supports. Funding is also available for specialist innovative projects through Defence Science and Technology.